RFK Jr. Announces HHS Plan To Curb Antidepressant Prescribing

HHS will push deprescribing, nonmedication treatments, provider training and CMS billing guidance after RFK Jr.'s May 4 announcement targeting SSRI overuse.

Overview

A summary of the key points of this story verified across multiple sources.

1.

On May 4, Health and Human Services Secretary Robert F. Kennedy Jr. announced a federal initiative at a Make America Healthy Again Institute summit to curb antidepressant prescribing and promote deprescribing when clinically indicated.

2.

Kennedy has long targeted SSRIs and has claimed without evidence that the drugs are linked to violence and that withdrawal is harder than heroin, claims experts have debunked.

3.

The American Psychiatric Association said it supports research, training and clinician reimbursement but warned that framing the crisis as overprescribing oversimplifies access gaps and workforce shortages, according to its statement.

4.

A 2025 survey, including over 30,000 adults, found roughly 16.6% to nearly 17% of respondents used antidepressants, and other data show about 40% received counseling and 11.4% took prescription medication for depression.

5.

HHS said agencies will evaluate prescribing trends, elevate nonmedication treatments, publish a prescribing report, train providers at more than 1,400 federally qualified health centers and implement CMS billing guidance to reimburse deprescribing.

Written using shared reports from
8 sources
.
Report issue

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

Center-leaning sources frame Kennedy as a sensational, dangerous actor by using loaded descriptors such as 'anti‑vaccine health secretary,' 'false and dangerous claims,' and 'heinous claim,' and by foregrounding expert rebuttals. They prioritize mental-health experts' debunking, spotlight extreme statements as source content, and structure coverage to emphasize public-health risk over policy nuance.